Cited by 924Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions

The DOI matches its Crossref record; 982 of the 982 references it cites were found in a registry or an index.

Drug-induced liver injury

Open access

Andrade, Raul J., Chalasani, Naga, Björnsson, Einar S., Suzuki, Ayako, Kullak-Ublick, Gerd A., Watkins, Paul B., Devarbhavi, Harshad, Merz, Michael, Lucena, M. Isabel, Kaplowitz, Neil, Aithal, Guruprasad P.·2019·Nature Reviews Disease Primers

DOI 10.1038/s41572-019-0105-0

Open this paper in CoChat — free account Open PDF

Abstract

Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as an unpredictable event with many drugs in common use. Drugs can be harmful to the liver in susceptible individuals owing to genetic and environmental risk factors. These risk factors modify hepatic metabolism and excretion of the DILI-causative agent leading to cellular stress, cell death, activation of an adaptive immune response and a failure to adapt, with progression to overt liver injury. Idiosyncratic DILI is a relative rare hepatic disorder but can be severe and, in some cases, fatal, presenting with a variety of phenotypes, which mimic other hepatic diseases. The diagnosis of DILI relies on the exclusion of other aetiologies of liver disease as specific biomarkers are still lacking. Clinical scales such as CIOMS/RUCAM can support the diagnostic process but need refinement. A number of clinical variables, validated in prospective cohorts, can be used to predict a more severe DILI outcome. Although no pharmacological therapy has been adequately tested in randomized clinical trials, corticosteroids can be useful, particularly in the emergent form of DILI related to immune-checkpoint inhibitors in patients with cancer.

Integrity signals

Registry

Crossref · 10.1038/s41572-019-0105-0

Cites

982 of 982 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

Cites a retracted work: 10.1128/aac.04976-14
Major
The cited work was retracted on 2015-12-28 (notice 10.1128/aac.04976-14), before this paper was published (2019-08-22). Its authors could have known.
Cited work 10.1128/aac.04976-14 · retracted 2015-12-28 · notice 10.1128/aac.04976-14 · this paper published 2019-08-22
Cites a retracted work: 10.1016/j.jhep.2018.04.024
Major
The cited work was retracted on 2018-05-03 (notice 10.1016/j.jhep.2018.04.024), before this paper was published (2019-08-22). Its authors could have known.
Cited work 10.1016/j.jhep.2018.04.024 · retracted 2018-05-03 · notice 10.1016/j.jhep.2018.04.024 · this paper published 2019-08-22

2 of 2

2 retracted

Items 201–400 of 982

L-Asparaginase
Haskell, C. M., Canellos, G. P., Leventhal, B. G., Carbone, P. P., Block, J. B., Serpick, A. A., & Selawry, O. S. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911062811902 · Cited by 266
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
Lewis, J. H., Ranard, R. C., Caruso, A. C., Jackson, L. K., Mullick, F. G., Ishak, K. G., Seeff, L. B., & Zimmerman, H. J. (1989) · Hepatology · doi:10.1002/hep.1840090504 · Cited by 265
Thioredoxin-2 Inhibits Mitochondria-Located ASK1-Mediated Apoptosis in a JNK-Independent Manner
Zhang, R., Al‐Lamki, R. S., Bai, L., Streb, J. W., Miano, J. M., Bradley, J. R., & Wang, M. (2004) · Circulation Research · doi:10.1161/01.res.0000130525.37646.a7 · Cited by 265
Survival in patients with HIV infection and viral hepatitis B or C
Bonacini, M., Louie, S. G., Bzowej, N. H., & Wohl, A. R. (2004) · AIDS · doi:10.1097/00002030-200410210-00008 · Cited by 264
Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione Toxicity
Radjendirane, V., Joseph, P., Lee, Y.-H., Kimura, S., Klein–Szanto, A. J., Gonzalez, F. J., & Jaiswal, A. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7382 · Cited by 262
Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen
Dinkova‐Kostova, A. T., & Talalay, P. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00300-2 · Cited by 259
Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury
Monshi, M. M., Faulkner, L., Gibson, A., Jenkins, R. E., Farrell, J., Earnshaw, C. J., Alfirevic, A., Cederbrant, K., Daly, A. K., French, N. S., et al. (2012) · Hepatology · doi:10.1002/hep.26077 · Cited by 259
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
Curtis, J. R., Beukelman, T., Onofrei, A., Cassell, S., Greenberg, J. D., Kavanaugh, A., Reed, G., Strand, V., & Kremer, J. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101378 · Cited by 258
Thiols in Cellular Redox Signalling and Control
Moran, L. K., Gutteridge, J. M. C., & Quinlan, G. J. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372904 · Cited by 256
Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice
Gong, S., Lan, T., Zeng, L., Luo, H., Yang, X., Li, N., Chen, X., Liu, Z., Li, R., Win, S., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.024 · Cited by 254
Self-citation
Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future
Senior, J. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.108 · Cited by 252
Oral Medications With Significant Hepatic Metabolism at Higher Risk for Hepatic Adverse Events
Lammert, C. S., Bjornsson, E. S., Niklasson, A., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.23317 · Cited by 251
Self-citation
Mechanisms of acetaminophen-induced cell death in primary human hepatocytes
Xie, Y., McGill, M. R., Dorko, K., Kumer, S. C., Schmitt, T. M., Forster, J., & Jaeschke, H. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.05.010 · Cited by 250
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial
Lewis, J. H., Mortensen, M. E., Zweig, S., Fusco, M. J., Medoff, J. R., & Belder, R. (2007) · Hepatology · doi:10.1002/hep.21848 · Cited by 248
Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
Sanne, I., Momméja-Marin, H., Hinkle, J. E., Bartlett, J. A., Lederman, M. M., Maartens, G., Wakeford, C., Shaw, A. L., Quinn, J., Gish, R. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428093 · Cited by 248
Importance and Regulation of Hepatic Glutathione
DeLeve, L. D., & Kaplowitz, N. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040481 · Cited by 247
Self-citation
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Stewart, J. D., Horváth, R., Baruffini, E., Ferrero, I., Bulst, S., Watkins, P. B., Fontana, R. J., Day, C. P., & Chinnery, P. F. (2010) · Hepatology · doi:10.1002/hep.23891 · Cited by 245
Self-citation
Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors
Ernest, C. S., Hall, S. D., & Jones, D. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075416 · Cited by 244
Ipilimumab associated hepatitis: imaging and clinicopathologic findings
Kim, K. W., Ramaiya, N. H., Krajewski, K. M., Jagannathan, J. P., Tirumani, S. H., Srivastava, A., & Ibrahim, N. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9939-6 · Cited by 236
Drug-induced autoimmune-like hepatitis
Czaja, A. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1611-4 · Cited by 235
Hepatotoxicity Associated with Supplements Containing Chinese Green Tea (Camellia sinensis)
Bonkovsky, H. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00020 · Cited by 231
Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort
Church, R. J., Kullak‐Ublick, G. A., Aubrecht, J., Bonkovsky, H. L., Chalasani, N., Fontana, R. J., Goepfert, J. C., Hackman, F., King, N. M. P., Kirby, S., et al. (2019) · Hepatology · doi:10.1002/hep.29802 · Cited by 231
Self-citation
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response
Kozyra, M., Ingelman‐Sundberg, M., & Lauschke, V. M. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.33 · Cited by 230
Clinically Significant Drug Interactions with Cyclosporin
Campana, C., Regazzi, M. B., Buggia, I., & Molinaro, M. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630020-00004 · Cited by 228
Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria
Krähenbühl, S., Talos, C., Fischer, S., & Reichen, J. (1994) · Hepatology · doi:10.1002/hep.1840190228 · Cited by 228
Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor
Chen, Y., Ferguson, S., Negishi, M., & Goldstein, J. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058818 · Cited by 226
Use of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic
LoBue, P. A., & Moser, K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-390oc · Cited by 223
The safety profile of the fluoroquinolones
Bertino, J., & Fish, D. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80053-3 · Cited by 223
A prospective nationwide study of drug-induced liver injury in Korea
Suk, K. T., Kim, D. J., Kim, C. H., Park, S. H., Yoon, J. H., Kim, Y. S., Baik, G. H., Kim, J. B., Kweon, Y. O., Kim, B. I., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.138 · Cited by 221
Apoptosis: Cell death defined by caspase activation
Afshin Samali, A., Zhivotovsky, B., Jones, D. P., Nagata, S., & Orrenius, S. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400520 · Cited by 220
MiR-122 in hepatic function and liver diseases
Hu, J., Xu, Y., Hao, J., Wang, S., Li, C., & Meng, S. (2012) · Protein & Cell · doi:10.1007/s13238-012-2036-3 · Cited by 219
Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset
Fontana, R. J., Hayashi, P. H., Gu, J., Reddy, K. R., Barnhart, H., Watkins, P. B., Serrano, J., Lee, W. M., Chalasani, N., Stolz, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.045 · Cited by 218
Self-citation
Statins and Liver Toxicity: A Meta‐Analysis
de Denus, S., Spinler, S. A., Miller, K., & Peterson, A. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.6.584.34738 · Cited by 218
Evaluation of Liver Function in Type 2 Diabetic Patients During Clinical Trials
Lebovitz, H. E., Kreider, M. S., & Freed, M. I. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.815 · Cited by 218
Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug Concentrations
Stevens, D. A., Espiritu, M., & Parmar, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3407-3411.2004 · Cited by 218
Mechanism of isoniazid‐induced hepatotoxicity: then and now
Metushi, I. G., Uetrecht, J., & Phillips, E. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12885 · Cited by 218
COMPLICATIONS OF CO-TRIMOXAZOLE IN TREATMENT OF AIDS-ASSOCIATED PNEUMOCYSTIS CARINII PNEUMONIA IN HOMOSEXUAL MEN
Jaffe, H., Ammann, A., Abrams, D., Lewis, B. J., & Golden, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90627-x · Cited by 217
Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection
Menzies, D., Long, R., Trajman, A., Dion, M.-J., Yang, J., Jahdali, H. A., Memish, Z. A., Khan, K., Gardam, M. A., Hoeppner, V., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00003 · Cited by 217
Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs
Chitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216
Finding New Treatments for Diabetes — How Many, How Fast . . . How Good?
Nathan, D. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068294 · Cited by 216
Antiretroviral drugs and liver injury
Soriano, V., Puoti, M., García‐Gascó, P., Rockstroh, J. K., Benhamou, Y., Barreiro, P., & McGovern, B. (2008) · AIDS · doi:10.1097/qad.0b013e3282f0e2fd · Cited by 215
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump
Aleo, M. D., Luo, Y., Swiss, R., Bonin, P. D., Potter, D. M., & Will, Y. (2014) · Hepatology · doi:10.1002/hep.27206 · Cited by 215
Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity
Lucena, M. I., Camargo, R., Andrade, R. J., Perez-Sanchez, C. J., & De La Cuesta, F. S. (2001) · Hepatology · doi:10.1053/jhep.2001.20645 · Cited by 212
Self-citation
Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel
Savi, P., Herbert, J., Pflieger, A. M., Dol, F., Delebassée, D., Combalbert, J., DEFREYN, G., & Maffrand, J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90445-o · Cited by 212
Role of the Liver in Interorgan Homeostasis of Glutathione and Cyst(e)ine
Ookhtens, M., & Kaplowitz, N. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007167 · Cited by 211
Self-citation
Thiopurine-Induced Liver Injury in Patients With Inflammatory Bowel Disease: A Systematic Review
Gisbert, J. P., González‐Lama, Y., & Maté, J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01187.x · Cited by 209
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin
Zuckerman, J. M. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.010 · Cited by 208
Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors
Dieterich, D. T., Robinson, P. A., Love, J., & Stern, J. O. (2004) · Clinical Infectious Diseases · doi:10.1086/381450 · Cited by 206
The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: A stopped-flow kinetic study
Coles, B., Wilson, I., Wardman, P., Hinson, J. A., Nelson, S. D., & KETTERER, B. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90592-9 · Cited by 205
Recurrent Hepatitis Attributable to Halothane Sensitization in an Anesthetist
Klatskin, G., & Kimberg, D. V. (1969) · New England Journal of Medicine · doi:10.1056/nejm196903062801001 · Cited by 203
Epidemiology of Idiosyncratic Drug-Induced Liver Injury
Bell, L. N., & Chalasani, N. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1240002 · Cited by 203
Self-citation
In Vitro and In Vivo Evidence of the Importance of Organic Anion Transporters (OATs) in Drug Therapy
Burckhardt, G., & Burckhardt, B. C. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_2 · Cited by 199
Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial
Jasmer, R. M., Saukkonen, J. J., Blumberg, H. M., Daley, C. L., Bernardo, J., Vittinghoff, E., King, M. D., Kawamura, L. M., Hopewell, P. C., & for the Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00007 · Cited by 199
The natural history of histologically proved drug induced liver disease
Aithal, G. P., & Day, C. P. (1999) · Gut · doi:10.1136/gut.44.5.731 · Cited by 199
Self-citation
The Induction of Cytochrome P450 3A5 (CYP3A5) in the Human Liver and Intestine Is Mediated by the Xenobiotic Sensors Pregnane X Receptor (PXR) and Constitutively Activated Receptor (CAR)
Burk, O., Koch, I., Raucy, J. L., Hustert, E., Eichelbaum, M. F., Brockmöller, J., Zanger, U. M., & Wojnowski, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404949200 · Cited by 198
Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases
Ghabril, M., Bonkovsky, H. L., Kum, C., Davern, T., Hayashi, P. H., Kleiner, D. E., Serrano, J., Rochon, J., Fontana, R. J., & Bonacini, M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.025 · Cited by 196
Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality
Devarbhavi, H., Dierkhising, R., Kremers, W. K., Sandeep, M. S., Karanth, D., & Adarsh, C. K. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.287 · Cited by 195
Self-citation
Biosynthesis and biotransformation of glutathione S -Conjugates to toxic metabolites
Anders, M. W., Lash, L. H., Dekant, W., Elfarra, A. A., Dohn, D. R., & Reed, D. J. (1988) · Critical Reviews in Toxicology · doi:10.3109/10408448809037470 · Cited by 195
Incidence of drug-induced liver injury in medical inpatients
Meier, Y., Cavallaro, M., Roos, M., Pauli‐Magnus, C., Folkers, G., Meier, P. J., & Fattinger, K. E. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0888-z · Cited by 194
Jaundice after Repeated Exposure to Halothane: An Analysis of Reports to the Committee on Safety of Medicines
Inman, W. H. W., & Mushin, W. W. (1974) · BMJ · doi:10.1136/bmj.1.5896.5 · Cited by 194
Glutathione S‐transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug‐induced liver injury†
Lucena, M. I., Andrade, R. J., Martínez, C., Ulzurrun, E., García‐Martín, E., Borraz, Y., Fernández, M. C., Romero‐Gómez, M., Castiella, A., Planas, R., et al. (2008) · Hepatology · doi:10.1002/hep.22370 · Cited by 194
Self-citation
Diurnal variation in glutathione and cysteine redox states in human plasma
Blanco, R. A., Ziegler, T. R., Carlson, B. A., Cheng, P., Park, Y. H., Cotsonis, G., Accardi, C. J., & Jones, D. P. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.1016 · Cited by 192
An Update on Drug-induced Liver Injury
Devarbhavi, H. C. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.05.002 · Cited by 192
Self-citation
c‐Jun N‐terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)‐dependent pathway leading to inactivation of intramitochondrial Src
Win, S., Than, T. A., Min, R. W. M., Aghajan, M., & Kaplowitz, N. (2016) · Hepatology · doi:10.1002/hep.28486 · Cited by 191
Self-citation
Calcium uptake of a rat liver microsomal subcellular fraction in response to in vivo administration of carbon tetrachloride.
Moore, L., Davenport, G. R., & Landon, E. J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33820-6 · Cited by 190
Increased risk of antituberculosis drug‐induced hepatotoxicity in individuals with glutathione S ‐transferase M1 ‘null’ mutation
Roy, B., Chowdhury, A., Kundu, S., Santra, A. K., Dey, B., Chakraborty, M., & Majumder, P. P. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02585.x · Cited by 189
Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents
Suzman, D. L., Pelosof, L., Rosenberg, A., & Avigan, M. I. (2018) · Liver International · doi:10.1111/liv.13746 · Cited by 189
Effect of l -carnitine treatment for valproate-induced hepatotoxicity
Bohan, T. P., Helton, E. D., McDonald, I., König, S. A., Gazitt, S., Sugimoto, T., Scheffner, D., Cusmano, L., Li, S., & Koch, G. G. (2001) · Neurology · doi:10.1212/wnl.56.10.1405 · Cited by 188
Troglitazone-induced liver failure: a case study
Graham, D. J., Green, L., Senior, J. R., & Nourjah, P. A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01529-2 · Cited by 188
Immune pathomechanism of drug hypersensitivity reactions
Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.048 · Cited by 186
Acute liver failure in Sweden: etiology and outcome
Wei, G., Bergquist, A. M., Broomé, U., Lindgren, S. C., Wallerstedt, S. M., Almer, S. H., Sangfelt, P., Danielsson, A., Sandberg–Gertzén, H., Lööf, L., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01818.x · Cited by 185
Risk of Acute Liver Injury Associated With the Combination of Amoxicillin and Clavulanic Acid
Rodríguez, L. A. G. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440110099013 · Cited by 182
Comparative Tolerability of the HMG-CoA Reductase Inhibitors
Farmer, J. A., & Torre‐Amione, G. (2000) · Drug Safety · doi:10.2165/00002018-200023030-00003 · Cited by 181
Amiodarone Hepatotoxicity Simulating Alcoholic Liver Disease
Simon, J. B., Manley, P. N., Brien, J. F., & Armstrong, P. W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407193110308 · Cited by 181
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug‐induced liver injury†‡
Rochon, J., Protiva, P., Seeff, L. B., Fontana, R. J., Liangpunsakul, S., Watkins, P. B., Davern, T. J., & McHutchison, J. G. (2008) · Hepatology · doi:10.1002/hep.22442 · Cited by 180
Self-citation
Effects of Aspirin and Acetaminophen on the Liver
Zimmerman, H. J. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.3.333 · Cited by 180
Black cohosh and other herbal remedies associated with acute hepatitis
Whiting, P. W., Clouston, A. D., & Kerlin, P. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04886.x · Cited by 180
REGULATION OF CYP2B6 IN PRIMARY HUMAN HEPATOCYTES BY PROTOTYPICAL INDUCERS
Faucette, S. R., Wang, H., Hamilton, G. A., Jolley, S. L., Gilbert, D., Lindley, C. M., Yan, B., Negishi, M., & LeCluyse, E. L. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.348 · Cited by 179
Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic
DE VALLE, M. B., AV KLINTEBERG, V., ALEM, N., OLSSON, R., & BJÖRNSSON, E. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03117.x · Cited by 179
Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis
Dara, L., Johnson, H. S., Suda, J., Win, S., Gaarde, W. A., Han, D., & Kaplowitz, N. (2015) · Hepatology · doi:10.1002/hep.27939 · Cited by 178
Self-citation
Hepatotoxicity associated with antiepileptic drugs
Bjornsson, E. S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01009.x · Cited by 176
Clinical Syndromes and Consequences of Antiretroviral-Related Hepatotoxicity5, 1, 3
Núñez, M. (2010) · Hepatology · doi:10.1002/hep.23716 · Cited by 176
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
Höhn, D., Melnick, J., Stagg, R., Altman, D. G., Friedman, M. A., Ignoffo, R. J., Ferrell, L., & Lewis, B. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.1.98 · Cited by 176
Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis*1, *2
Whiting, J. F. (1995) · Hepatology · doi:10.1016/0270-9139(95)90639-8 · Cited by 175
Hepatocellular Mitochondrial Alterations in Patients With Chronic Hepatitis C: Ultrastructural and Biochemical Findings
Barbaro, G., Lorenzo, G. D., Asti, A., Ribersani, M., Belloni, G., Grisorio, B., Filice, G., & Barbarini, G. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01294.x · Cited by 175
Redox Regulation of Caspase-3(-like) Protease Activity: Regulatory Roles of Thioredoxin and Cytochrome c
Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., & Yodoi, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6689 · Cited by 174
Inhibition of ATP-dependent microsomal Ca2+ sequestration during oxidative stress and its prevention by glutathione.
Jones, D. P., Thor, H., Smith, M. T., Jewell, S. A., & Orrenius, S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32421-9 · Cited by 173
Drug-Induced Liver Injury Associated with Statins
Russo, M. W., Scobey, M., & Bonkovsky, H. L. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1240010 · Cited by 173
Tolcapone and Hepatotoxic Effects
Olanow, C. W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.263 · Cited by 173
l ‐Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
Vivo, D. C. D., Bohan, T. P., Coulter, D. L., Dreifuss, F. E., Greenwood, R., Nordli, D. R., Shields, W. D., Stafstrom, C. E., & Tein, I. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01315.x · Cited by 172
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis
Donaldson, P. T., Farrant, M. J., Wilkinson, M., Hayllar, K. M., Portmann, B. C., & Williams, R. L. (1991) · Hepatology · doi:10.1002/hep.1840130119 · Cited by 171
Hepatic reactions associated with ketoconazole in the United Kingdom.
Lake‐Bakaar, G., Scheuer, P. J., & Sherlock, S. (1987) · BMJ · doi:10.1136/bmj.294.6569.419 · Cited by 171
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine
Walker, U. A., Bäuerle, J., Laguno, M., Murillas, J., Mauss, S., Schmutz, G., Setzer, B., Miquel, R., Gatell, J. M., & Mallolas, J. (2004) · Hepatology · doi:10.1002/hep.20074 · Cited by 171
Hepatotoxicity related to antirheumatic drugs
Aithal, G. P. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.214 · Cited by 170
Self-citation
Immune-mediated drug-induced liver disease
Liu, Z.-X., & Kaplowitz, N. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00025-9 · Cited by 170
Self-citation
United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity
Mahady, G. B., Dog, T. L., Barrett, M. L., Chavez, M. L., Gardiner, P. M., Ko, R., Marles, R. J., Pellicore, L. S., Giancaspro, G. I., & Sarma, D. N. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31816054bf · Cited by 170
Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature.
Visser, K., & van der Heijde, D. M. F. M. (2009) · PubMed · Cited by 169
HEPATOBILIARY AND PANCREATIC COMPLICATIONS OF CYCLOSPORINE THERAPY IN 466 RENAL TRANSPLANT RECIPIENTS
Lorber, M. I., Buren, C. T. V., Flechner, S. M., Williams, C., & Kahan, B. D. (1987) · Transplantation · doi:10.1097/00007890-198701000-00009 · Cited by 169
Identification of a Reactive Metabolite of Terbinafine: Insights into Terbinafine-Induced Hepatotoxicity
Iverson, S. L., & Uetrecht, J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002029 · Cited by 169
Causality assessment methods in drug induced liver injury: Strengths and weaknesses
García-Cortés, M., Stephens, C., Lucena, M. I., Fernández-Castañer, A., & Andrade, R. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.007 · Cited by 169
Self-citation
Inhibition of hepatocyte plasma membrane Ca2+‐ATPase activity by menadione metabolism and its restoration by thiols
Nicotera, P., Moore, M., Mirabelli, F., Bellomo, G., & Orrenius, S. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)81131-5 · Cited by 168
Chronic Active Hepatitis and Severe Hepatic Necrosis Associated with Nitrofurantoin
Sharp, J. R., Ishak, K. G., & Zimmerman, H. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-1-14 · Cited by 168
Adverse Effects of Macrolide Antibacterials
Periti, P., Mazzei, T., Mini, E., & Novelli, A. (1993) · Drug Safety · doi:10.2165/00002018-199309050-00004 · Cited by 167
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C
Macı́as, J., Castellano, V., Merchante, N., Palacios, R. B., Mira, J. A. L., Sáez, C., García-García, J. Á., Lozano, F., Gómez-Mateos, J. M., & Pineda, J. A. (2004) · AIDS · doi:10.1097/00002030-200403260-00007 · Cited by 167
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
Eliasson, E., & Kenna, J. G. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09316-2 · Cited by 167
Suspected drug-induced liver fatalities reported to the WHO database
BJORNSSON, E., & Olsson, R. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.06.004 · Cited by 166
Evaluation of oxidative stress during apoptosis and necrosis caused by carbon tetrachloride in rat liver
Sun, F. Y., Hamagawa, E., Tsutsui, C., Ono, Y., Ogiri, Y., & Kojo, S. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00098-3 · Cited by 165
Idiosyncratic Liver Injury: Challenges and Approaches
Watkins, P. B. (2005) · Toxicologic Pathology · doi:10.1080/01926230590888306 · Cited by 164
Self-citation
Nonsteroidal Anti-Inflammatory Drug–Induced Hepatotoxicity
Aithal, G. P., & Day, C. P. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.004 · Cited by 163
Self-citation
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir
Sulkowski, M., Mehta, S. H., Chaisson, R. E., Thomas, D. L., & Moore, R. D. (2004) · AIDS · doi:10.1097/00002030-200411190-00008 · Cited by 163
Treatment of PD‐1−/− mice with amodiaquine and anti‐CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients
Metushi, I. G., Hayes, M. A., & Uetrecht, J. (2014) · Hepatology · doi:10.1002/hep.27549 · Cited by 161
Serious liver disease induced by infliximab
Tobón, G. J., Cañas, C. A., Jaller, J. J., Restrepo, J., & Anaya, J. (2006) · Clinical Rheumatology · doi:10.1007/s10067-005-0169-y · Cited by 160
Involvement of the cystathionine pathway in the biosynthesis of glutathione by isolated rat hepatocytes
Beatty, P. W., & Reed, D. J. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90009-0 · Cited by 160
Metabolic and toxic effects of mithramycin during tumor therapy
Kennedy, B. J. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80044-4 · Cited by 160
Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases
Danielson, U. H., Esterbauer, H., & Mannervik, B. (1987) · Biochemical Journal · doi:10.1042/bj2470707 · Cited by 159
The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug‐induced liver injury
Bjornsson, E. S., Kalaitzakis, E., & Olsson, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03330.x · Cited by 158
Detoxification of Reactive Oxygen Species by A Nonpeptidyl Mimic of Superoxide Dismutase Cures Acetaminophen–Induced Acute Liver Failure in the Mouse
Ferret, P., Hammoud, R., Tulliez, M., Tran, A., Trebeden‐Negre, H., Jaffray, P., Malassagne, B., Calmus, Y., Weill, B. J., & Batteux, F. (2001) · Hepatology · doi:10.1053/jhep.2001.24267 · Cited by 158
Safety and tolerance of recombinant interferon alfa-2a (roferon®-A) in Cancer Patients
Jones, G. J., & Itri, L. M. (1986) · Cancer · doi:10.1002/1097-0142(19860415)57:8+ · Cited by 157
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: A report of 3 cases
Noppers, I. M., Niesters, M., Aarts, L. P. H. J., Bauer, M. C. R., Drewes, A. M., Dahan, A., & Sarton, E. Y. (2011) · Pain · doi:10.1016/j.pain.2011.03.026 · Cited by 157
Peliosis hepatis in recipients of renal transplants.
Degott, C., RUEFF, B., Kreis, H., DUBOUST, A., Potet, F., & Benhamou, J. P. (1978) · Gut · doi:10.1136/gut.19.8.748 · Cited by 157
Hepatic Veno-Occlusive Disease Due to Pyrrolizidine (Senecio) Poisoning in Arizona
Stillman, A. E., Huxtable, R. J., Consroe, P. F., Kohnen, P. W., & Smith, S. M. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)32224-3 · Cited by 156
The Treatment of Acetaminophen Poisoning
Prescott, L. F., & Critchley, J. (1983) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.23.040183.000511 · Cited by 156
Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure
Khandelwal, N., James, L. P., Sanders, C. M., Larson, A. M., Lee, W. M., & and the Acute Liver Failure Study Group (2010) · Hepatology · doi:10.1002/hep.24060 · Cited by 155
Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Zhou, S., Chan, E., Lim, L. Y., Boelsterli, U. A., Li, S., Wang, J., Zhang, Q., Huang, M., & Xu, A. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335450 · Cited by 155
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
Andrade, R. J., Lucena, M. I., Alonso, A. O., García‐Cortés, M., Garcı́a-Ruiz, E., Benitez, R. A., Fernández, C. M. A., Peláez, G. I. C., Romero, M., Corpas, R., et al. (2004) · Hepatology · doi:10.1002/hep.20215 · Cited by 153
Self-citation
Rat glutathione transferase 8‐8, an enzyme efficiently detoxifying 4‐hydroxyalk‐2‐enals
Jensson, H., Guthenberg, C., Ålin, P., & Mannervik, B. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80743-8 · Cited by 153
Drug‐induced liver injury at an Asian center: a prospective study
Wai, C. T., Tan, B., Chan, C., Sutedja, D. S., Lee, Y.-M., Khor, C. J. L., & Lim, S. G. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01461.x · Cited by 152
Causality Assessment Versus Guilt–By–Association in Drug Hepatotoxicity
Kaplowitz, N. (2001) · Hepatology · doi:10.1053/jhep.2001.21083 · Cited by 152
Self-citation
Pathogenesis of ceftriaxone-associated biliary sludge
Shiffman, M. L., Keith, F. B., & Moore, E. W. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90486-k · Cited by 152
PROTEIN TARGETS OF XENOBIOTIC REACTIVE INTERMEDIATES
Pumford, N. R., & Halmes, N. C. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.91 · Cited by 151
In Vitro Metabolism of Tolcapone to Reactive Intermediates: Relevance to Tolcapone Liver Toxicity
Smith, K. S., Smith, P. L., Heady, T. N., Trugman, J. M., Harman, W. D., & Macdonald, T. L. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025569n · Cited by 147
Drug-induced cholestasis
Velayudham, L. S., & Farrell, G. C. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.3.287 · Cited by 147
Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States?
Vuppalanchi, R., Liangpunsakul, S., & Chalasani, N. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01019.x · Cited by 146
Self-citation
Pharmacogenetics of drug‐induced liver injury†
Russmann, S., Jetter, A., & Kullak-Ublick, G. A. (2010) · Hepatology · doi:10.1002/hep.23720 · Cited by 145
Self-citation
Monitoring methotrexate‐induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
Aithal, G. P., Haugk, B., Das, S., Card, T. R., Burt, A. D., & Record, C. O. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2004.01819.x · Cited by 145
Self-citation
Hepatitis C Virus Coinfection Increases Mortality in HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era: Data from the HIV Atlanta VA Cohort Study
Anderson, K. B., Guest, J. L., & Rimland, D. (2004) · Clinical Infectious Diseases · doi:10.1086/425360 · Cited by 144
Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic
Fréneaux, E., Labbe, G., Lettéron, P., Dinh, T. L., Degott, C., Genève, J., Larrey, D. G., & Pessayre, D. (1988) · Hepatology · doi:10.1002/hep.1840080513 · Cited by 144
Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications
Dara, L., Liu, Z., & Kaplowitz, N. (2015) · Liver International · doi:10.1111/liv.12988 · Cited by 144
Self-citation
Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug‐induced liver injury
GARCÍA‐CORTÉS, M., LUCENA, M. I., PACHKORIA, K., BORRAZ, Y., HIDALGO, R., ANDRADE, R. J., & ON BEHALF OF THE SPANISH GROUP FOR THE STUDY OF DRUG‐INDUCED LIVER DISEASE (GRUPO DE ESTUDIO PARA LAS HEPATOPATÍAS ASOCIADAS A MEDICAMENTOS, G. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03655.x · Cited by 143
Self-citation
Review Article: Carnitine, Valproate, and Toxicity
Coulter, D. L. (1991) · Journal of Child Neurology · doi:10.1177/088307389100600102 · Cited by 142
A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs
Rodríguez, G., Duque, Castellsague, Perez‐Gutthann, S., & Stricker, B. H. C. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00095.x · Cited by 141
MRP2 haplotypes confer differential susceptibility to toxic liver injury
Choi, J. H., Ahn, B. M., Yi, J., Lee, J. H., Lee, J. H., Nam, S. W., Chon, C. Y., Han, K., Ahn, S. H., Jang, I., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236337.41799.b3 · Cited by 141
Safety of Oral Terbinafine
Hall, M. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890460029004 · Cited by 141
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I., Robles-Diaz, M., Garcia-Muñoz, B., Stephens, C., Ortega-Alonso, A., Garcia-Cortes, M., González-Jimenez, A., Sanabria-Cabrera, J. A., Moreno, I., Fernandez, M. C., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.003 · Cited by 140
Self-citation
Therapeutic Options for the Treatment of Tinea Capitis Caused by Trichophyton Species: Griseofulvin Versus the New Oral Antifungal Agents, Terbinafine, Itraconazole, and Fluconazole
Gupta, A. K., Adam, P., Dlova, N. C., Lynde, C. W., Hofstader, S. L. R., Morar, N., Aboobaker, J., & Summerbell, R. C. (2001) · Pediatric Dermatology · doi:10.1046/j.1525-1470.2001.01978.x · Cited by 139
Important Elements for the Diagnosis of Drug-Induced Liver Injury
Agarwal, V. K., McHutchison, J. G., & Hoofnagle, J. H. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.02.008 · Cited by 138
Autoimmune Hepatitis Triggered by Statins
Alla, V., Abraham, J. P., Siddiqui, J., Raina, D., Wu, G. Y., Chalasani, N., & Bonkovsky, H. L. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00018 · Cited by 137
Self-citation
Safety of rosuvastatin
Shepherd, J., Hunninghake, D. B., Stein, E. A., Kastelein, J. J. P., Harris, S., Pears, J. S., & Hutchinson, H. G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.049 · Cited by 137
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements
Bonkovsky, H. L., Kleiner, D. E., Gu, J., Odin, J. A., Russo, M. W., Navarro, V. M., Fontana, R. J., Ghabril, M. S., Barnhart, H., Hoofnagle, J. H., et al. (2017) · Hepatology · doi:10.1002/hep.28967 · Cited by 137
A missense variant in PTPN22 is a risk factor for drug-induced liver injury
Cirulli, E. T., Nicoletti, P., Abramson, K., Andrade, R. J., Bjornsson, E. S., Chalasani, N., Fontana, R. J., Hallberg, P., Li, Y. J., Lucena, M. I., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.034 · Cited by 137
Self-citation
Genetic association studies in drug-induced liver injury
Daly, A. K., & Day, C. P. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.605790 · Cited by 136
Liver Enzyme Monitoring in Patients Treated With Troglitazone
Graham, D. J. (2001) · JAMA · doi:10.1001/jama.286.7.831 · Cited by 136
Early drug discovery and the rise of pharmaceutical chemistry
Jones, A. W. (2011) · Drug Testing and Analysis · doi:10.1002/dta.301 · Cited by 136
Amino Acid Substitutions At Position 38 of the Drβ Polypeptide Confer Susceptibility to and Protection From Primary Sclerosing Cholangitis
Farrant, M. J., Doherty, D. G., Donaldson, P. T., Vaughan, R. W., Hayllar, K. M., Welsh, K. I., Eddleston, A. L. W. F., & Williams, R. L. (1992) · Hepatology · doi:10.1002/hep.1840160217 · Cited by 135
Hepatic toxicity of unmodified and time-release preparations of niacin
Rader, J. I., Calvert, R. J., & Hathcock, J. N. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90018-7 · Cited by 135
Pyrazinamide and Rifampin vs Isoniazid for the Treatment of Latent Tuberculosis
McNeill, L., Allen, M. G., Estrada, C. A., & Cook, P. (2003) · CHEST Journal · doi:10.1378/chest.123.1.102 · Cited by 135
Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury
Orman, E. S., Conjeevaram, H. S., Vuppalanchi, R., Freston, J. W., Rochon, J., Kleiner, D. E., & Hayashi, P. H. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.019 · Cited by 134
Hepatotoxicity of Mercaptopurine
Einhorn, M., & Davidsohn, I. (1964) · JAMA · doi:10.1001/jama.1964.03060350028007 · Cited by 134
Detection of anti-isoniazid and anti–cytochrome P450 antibodies in patients with isoniazid-induced liver failure
Metushi, I. G., Sanders, C. M., Lee, W. M., & Uetrecht, J. (2013) · Hepatology · doi:10.1002/hep.26564 · Cited by 134
Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia
Raetz, E. A., & Salzer, W. L. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181e6f003 · Cited by 134
Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs
Ibáñez, L., Pérez, E., Vidal, X., & Laporte, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00231-3 · Cited by 133
Ketoconazole-associated hepatic injury
Stricker, B. H. C., Blok, A. P. R., Bronkhorst, F., Parys, G. V., & Desmet, V. J. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80495-0 · Cited by 133
Statins in liver disease
Argo, C. K., Loria, P., Caldwell, S. H., & Lonardo, A. (2008) · Hepatology · doi:10.1002/hep.22402 · Cited by 132
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions
Aithal, G. P., Rawlins, M. D., & Day, C. P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80127-0 · Cited by 132
Self-citation
Evaluation of Hepatotoxic Potential of Drugs by Inhibition of Bile-Acid Transport in Cultured Primary Human Hepatocytes and Intact Rats
Kostrubsky, V. E. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg217 · Cited by 132
The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
Björnsson, E., & Davidsdottir, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.021 · Cited by 131
Chemoprotection by Organosulfur Inducers of Phase 2 Enzymes: Dithiolethiones and Dithiins
Kensler, T. W., Curphey, T. J., Maxiutenko, Y., & Roebuck, B. D. (2000) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2000.17.1-4.3 · Cited by 131
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer a phase I-II study
Phillips, G. L., Fay, J. W., Herzig, G. P., Herzig, R. H., Weiner, R. S., Wolff, S. N., Lazarus, H. M., Karanes, C., Ross, W. E., & Kramer, B. S. (1983) · Cancer · doi:10.1002/1097-0142(19831115)52:10 · Cited by 130
The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers
Harrill, A. H., Roach, J. M., Fier, I., Eaddy, J. S., Kurtz, C. L., Antoine, D. J., Spencer, D. M., Kishimoto, T., Pisetsky, D. S., Park, B. K., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.40 · Cited by 130
Self-citation
Veno-Occlusive Disease of the Liver After Chemotherapy of Acute Leukemia
Griner, P. F., ELBADAWI, A., & PACKMAN, C. H. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-5-578 · Cited by 130
Veno-occlusive disease of the liver secondary to ingestion of comfrey.
Weston, C. F. M., Cooper, B. T., Davies, J. D., & Levine, D. F. (1987) · BMJ · doi:10.1136/bmj.295.6591.183 · Cited by 129
Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms
Seeff, L. B., Bonkovsky, H. L., Navarro, V. J., & Wang, G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.12.004 · Cited by 129
Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase
Du, K., Williams, C. D., McGill, M. R., & Jaeschke, H. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.09.002 · Cited by 128
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcome
Lee, J. L., Gooley, T., Bensinger, W., Schiffman, K., & McDonald, G. B. (1999) · Transplantation and Cellular Therapy · doi:10.1016/s1083-8791(99)70006-6 · Cited by 128
Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.
Sheets, J. J., & Mason, J. I. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07769-4 · Cited by 127
Hepatotoxicity of Clozapine
Hummer, M., Kurz, M., Kurzthaler, I., OBERBAUER, H., Miller, C., & Fleischhacker, W. W. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00012 · Cited by 126
Serious Adverse Cutaneous and Hepatic Toxicities Associated With Nevirapine Use by Non???HIV-Infected Individuals
Patel, S. M., Johnson, S., Belknap, S. M., Chan, J., Sha, B. E., & Bennett, C. L. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200402010-00003 · Cited by 126
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective
Kenna, J. G., Taskar, K. S., Battista, C., Bourdet, D. L., Brouwer, K. L. R., Brouwer, K. R., Dai, D., Funk, C., Hafey, M. J., Lai, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1222 · Cited by 126
Self-citation
Hepatotoxicity of Rifampin-Pyrazinamide and Isoniazid Preventive Therapy and Tuberculosis Treatment
van Hest, R., Baars, H., Kik, S. V., van Gerven, P., Trompenaars, M. E., Kalisvaart, N. A., Keizer, S. T., Borgdorff, M. W., Mensen, M., & Cobelens, F. G. J. (2004) · Clinical Infectious Diseases · doi:10.1086/422645 · Cited by 125
Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine
Martín‐Carbonero, L., Marina, N., Juan, G.-L., & Soriano, V. (2003) · HIV Clinical Trials · doi:10.1310/n4vt-3e9u-4bkn-crpw · Cited by 124
ADVERSE REACTIONS OF NITROFURANTOIN, TRIMETHOPRIM AND SULFAMETHOXAZOLE IN CHILDREN
Karpman, E., & Kurzrock, E. A. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000130653.74548.d6 · Cited by 124
Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
Björnsson, E., Jerlstad, P., Bergqvist, A., & Olsson, R. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510023846 · Cited by 123
Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B
Kuo, A., Dienstag, J. L., & Chung, R. T. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00017-5 · Cited by 123
Evolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges
Senior, J. R. (2014) · Drug Safety · doi:10.1007/s40264-014-0182-7 · Cited by 123
Hypersensitivity Reactions to Cancer Chemotherapeutic Agents
Weiss, R. B., & Bruno, S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-1-66 · Cited by 123
Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia
Douer, D., Aldoss, I. T., Lunning, M. A., Burke, P. W., Ramezani, L., Mark, L., Vrona, J., Park, J. H., Tallman, M. S., Avramis, V. I., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.2708 · Cited by 123
Death and liver transplantation within 2 years of onset of drug‐induced liver injury
Hayashi, P. H., Rockey, D. C., Fontana, R. J., Tillmann, H. L., Kaplowitz, N., Barnhart, H. X., Gu, J., Chalasani, N. P., Reddy, K. R., Sherker, A. H., et al. (2017) · Hepatology · doi:10.1002/hep.29283 · Cited by 123
Self-citation
Enflurane Hepatotoxicity
Lewis, J. H., Zimmerman, H. J., ISHAK, K. G., & MULLICK, F. G. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-984 · Cited by 122
Phenytoin hypersensitivity
Haruda, F. D. (1979) · Neurology · doi:10.1212/wnl.29.11.1480 · Cited by 121
Safety and efficacy of ?-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction
Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121
INVOLVEMENT OF ORGANIC ANION TRANSPORTING POLYPEPTIDES IN THE TRANSPORT OF TROGLITAZONE SULFATE: IMPLICATIONS FOR UNDERSTANDING TROGLITAZONE HEPATOTOXICITY
Nozawa, T., Sugiura, S., Nakajima, M., Goto, A., Yokoi, T., Nezu, J., Tsuji, A., & Tamai, I. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.291 · Cited by 121
Hepatic Injury Associated with Diphenylhydantoin Therapy. A Clinicopathologic Study of 20 Cases
Mullick, F. G., & Ishak, K. G. (1980) · American Journal of Clinical Pathology · doi:10.1093/ajcp/74.4.442 · Cited by 121
Hepatitis After Exposure to Halothane
Klion, F. M., SCHAFFNER, F., & POPPER, H. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-3-467 · Cited by 120
The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware
For the Drug Induced Liver Injury Network (DILIN), Vega, M., Verma, M., Beswick, D., Bey, S., Hossack, J., Merriman, N., Shah, A., & Navarro, V. (2017) · Drug Safety · doi:10.1007/s40264-017-0547-9 · Cited by 120
Drug‐induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006
Takikawa, H., Murata, Y., Horiike, N., Fukui, H., & Onji, M. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00486.x · Cited by 119
How Common Is Diclofenac-Associated Liver Injury? Analysis of 17,289 Arthritis Patients in a Long-Term Prospective Clinical Trial
Laine, L., Goldkind, L., Curtis, S., Connors, L., Yanqiong, Z., & Cannon, C. P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.149 · Cited by 119
Diclofenac induced hepatitis
Scully, L. J., Clarke, D., & Barr, R. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316809 · Cited by 119
Hepatic Veno-Occlusive Disease in a Renal Transplant Patient Receiving Azathioprine
Marubbio, A. T., & Danielson, B. D. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32476-x · Cited by 118
Risk of drug-induced liver injury from tumor necrosis factor antagonists
Björnsson, E. S., Gunnarsson, B. I., Gröndal, G., Jonasson, J. G., Einarsdottir, R., Ludviksson, B. R., Gudbjörnsson, B., & Olafsson, S. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.062 · Cited by 118
Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System
Goldberg, D. S., Forde, K. A., Carbonari, D. M., Lewis, J. D., Leidl, K. B. F., Reddy, K. R., Haynes, K., Roy, J. A., Sha, D., Marks, A. R., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.050 · Cited by 118

Flagged first, then by citations

Research works printed but not linked: 3

Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001).
Sanjuan-Jimenez, R. et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract]. Hepatology 66, 423A (2017).
Abu-Sbeih, H., Styskel, B., Blechazz, B., Chalasani, N. & Miller, E. Clinically significant hepatotoxicity due to immune checkpoint inhibitors is rare but leads to treatment discontinuations in high proportion. Hepatology 68, 25A (2018).

Sorted by citations

ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citation
Acute Pancreatitis: Diagnosis and Treatment
Szatmary, P., Grammatikopoulos, T., Cai, W., Huang, W., Mukherjee, R., Halloran, C. M., Beyer, G., & Sutton, R. (2022) · Drugs · doi:10.1007/s40265-022-01766-4 · Cited by 684
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Role of liver sinusoidal endothelial cells in liver diseases
Gracia‐Sancho, J., Caparrós, E., Fernández‐Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 436
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Self-citation

See all 924

Authors: Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., & Aithal, G. P.
Affiliations: Indiana University School of Medicine (US)
Duke University (US)
Novartis (Switzerland) (CH)
University of North Carolina at Chapel Hill (US)
St.John's Medical College Hospital (IN)
University of Zurich (CH)
Spanish Clinical Research Network (ES)
Nottingham University Hospitals NHS Trust (GB)
Corresponding author: Lucena, M. Isabel
ORCID: Chalasani, Naga
Suzuki, Ayako
Kullak-Ublick, Gerd A.
Watkins, Paul B.
Devarbhavi, Harshad
Merz, Michael
Lucena, M. Isabel
Kaplowitz, Neil
Aithal, Guruprasad P.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2019-08-22
Volume: 5
Issue: 1
Pages: 58-58
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-019-0105-0
OpenAlex: W1565605888
Cited by: 924
References: 982
Citations by year: 2026: 152 · 2025: 197 · 2024: 161 · 2023: 127 · 2022: 145 · 2021: 97 · 2020: 38
FWCI: 9.11
Type: journal article
Language: en
Open access: green
www.zora.uzh.ch
Licence: other-oa
www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords: drug-induced liver injury, idiosyncratic drug reactions, xenobiotic toxicity, genetic susceptibility, hepatic metabolism, immune response, corticosteroids, immune checkpoint inhibitors, hepatotoxicity
MeSH terms: Biopsy, Humans, Risk Factors, Biomarkers, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug-induced liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Cited works that were retracted

Citations

Cites

Cited by

Related

Metadata

Record

About these checks